comparemela.com

Latest Breaking News On - Molecular templates daily - Page 1 : comparemela.com

Molecular Templates, Inc (NASDAQ:MTEM) Short Interest Down 21 9% in May

Molecular Templates, Inc. (NASDAQ:MTEM – Get Free Report) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 132,100 shares, a drop of 21.9% from the April 30th total of 169,100 shares. Based on an average daily volume of 75,500 shares, the short-interest ratio […]

Molecular Templates, Inc (NASDAQ:MTEM) Shares Sold by Monashee Investment Management LLC

Molecular Templates, Inc (NASDAQ:MTEM) Shares Sold by Monashee Investment Management LLC
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Target N V Biotech Acquires 250,000 Shares of Molecular Templates, Inc (NASDAQ:MTEM) Stock

Target N V Biotech Acquires 250,000 Shares of Molecular Templates, Inc (NASDAQ:MTEM) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Silverarc Capital Management LLC Acquires Shares of 354,608 Molecular Templates, Inc (NASDAQ:MTEM)

Silverarc Capital Management LLC Acquires Shares of 354,608 Molecular Templates, Inc (NASDAQ:MTEM)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Silverarc Capital Management LLC Acquires Shares of 354,608 Molecular Templates, Inc (NASDAQ:MTEM)

Silverarc Capital Management LLC bought a new position in shares of Molecular Templates, Inc. (NASDAQ:MTEM – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 354,608 shares of the biotechnology company’s stock, valued at approximately $2,241,000. Silverarc Capital […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.